Literature DB >> 32969911

Postablative 131I SPECT/CT Is Much More Sensitive Than Cervical Ultrasonography for the Detection of Thyroid Remnants in Patients After Total Thyroidectomy for Differentiated Thyroid Cancer.

Iwona Bulzacka1, Jacek Makarewicz.   

Abstract

PURPOSE: Evaluation of utility of cervical ultrasound (US) for detection of thyroid remnants (ThR) in patients after thyroidectomy for differentiated thyroid cancer.
METHODS: Included were 154 consecutive patients (17-89 years, 123 female and 31 male patients), without known cancer residues or cervical lymph nodes metastases, admitted for ThR ablation with I, 14 to 20 weeks after surgery. Neck uptake of I (Tup) and thyroglobulin were determined, and location and volume of ThR detected by cervical US were recorded. On days 3 to 4 after ablation (1.7-4.6GBq, 46-124.3 mCi I), neck SPECT/CT was performed, and I uptake foci were assigned to one of the regions as described below. The anterior neck was divided into 2 compartments: superior and inferior to lower margin of thyroid cartilage, and each compartment was subdivided into middle and lateral regions (in SPECT/CT, posterolateral and anterolateral regions were also marked out). I uptake sites and ThR detected by US, if congruent with SPECT/CT, were counted and analyzed.
RESULTS: In total, 341 I uptake foci were found in 150 patients (97.4%) by SPECT/CT and 213 corresponding ThR in 118 patients (76.6%) by US. Ultrasound detected 30% to 46% of I uptake foci in superior lateral regions, 49% in pyramidal lobe/thyroglossal duct area (both P < 0.05), 74% to 77% in inferior lateral regions, and 22% in isthmus (both P > 0.05). Correlation between ThR volume and Tup was strong (r = 0.79), and that between ThR volume and thyroglobulin was weak (r = 0.24).
CONCLUSIONS: Ultrasound is less sensitive than I posttherapy scans for ThR detection in patients after thyroidectomy, especially for remnants located above the lower margin of thyroid cartilage.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32969911     DOI: 10.1097/RLU.0000000000003295

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment.

Authors:  Murat Tuncel; Alexis Vrachimis; Alfredo Campenni; Bart de Keizer; Frederik A Verburg; Michael C Kreissl; Petra Petranovic Ovcaricek; Tamara Geliashvili; Luca Giovanella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08       Impact factor: 10.057

2.  Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer.

Authors:  Aleksandra Ledwon; Ewa Paliczka-Cieślik; Aleksandra Syguła; Tomasz Olczyk; Aleksandra Kropińska; Agnieszka Kotecka-Blicharz; Kornelia Hasse-Lazar; Aneta Kluczewska-Gałka; Barbara Jarząb; Daria Handkiewicz-Junak
Journal:  Ann Nucl Med       Date:  2021-08-07       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.